Table: Oncolys Biopharma - Q1 parent results

Oncolys Biopharma

02/05/2018 07:00

May 2 (Reuters)- 
             Oncolys Biopharma Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Mar 31, 2018        Mar 31, 2017       Dec 31, 2018  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            33 mln              15 mln            230 mln     
                (+120.2 pct)         (-48.0 pct)        (+0.4 pct)   
  Operating     loss 302 mln        loss 235 mln        loss 1.40    
  Recurring     loss 310 mln        loss 241 mln        loss 1.40    
  Net           loss 311 mln        loss 242 mln        loss 1.40    
  EPS          loss 28.09 yen      loss 25.91 yen    loss 126.29 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T